We are live on ! Find out more

MYOK

MyoKardia, Inc. Common Stock

MYOK

Delisted

MYOK was delisted on the 16th of November, 2020.

63 hedge funds and large institutions have $233M invested in MyoKardia, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New

Increased

Maintained

Reduced

Closed

1,800% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 1

343% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 7

89% more capital invested

Capital invested by funds: $123M → $233M (+$110M)

40% more funds holding

Funds holding: 45 → 63 (+18)

Holders

Holders Change

+18

Holders Change %

+40%

% of All Funds

1.68%

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

% of All Funds

0.03%

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	Wellington Management Group Boston, Massachusetts	+$27M
2	CAM Cormorant Asset Management Boston, Massachusetts	+$15.3M
3	PHS PFM Health Sciences San Francisco, California	+$6.4M
4	Vanguard Group Malvern, Pennsylvania	+$3.87M
5	DCM Driehaus Capital Management Chicago, Illinois	+$3.76M

Top Sellers

Rank	Fund	Capital Flow
1	JP Morgan Chase New York	-$3.22M
2	CC Casdin Capital New York	-$344K
3	TCIM TIAA CREF Investment Management New York	-$39.8K
4	UBS Group Zurich, Switzerland	-$8K
5	Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	-$4.51K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	SIM 26 Spark Investment Management New York	$650K	+$500K	+27,700	+229%
27	27 Charles Schwab San Francisco, California	$640K	+$189K	+10,472	+37%
28	EA 28 Emerald Acquisition Seattle, Washington	$634K	+$700K	+38,792	New
29	FIM 29 Fernwood Investment Management Quincy, Massachusetts	$523K	+$72.2K	+4,000	+14%
30	30 Bank of New York Mellon New York	$491K	+$153K	+8,487	+39%
31	LCM 31 Laurion Capital Management New York	$480K	+$530K	+29,347	New
32	32 Victory Capital Management San Antonio, Texas	$444K	+$491K	+27,180	New
33	PIM 33 Partner Investment Management San Francisco, California	$417K	+$168K	+9,311	+58%
34	FT 34 Fiduciary Trust Boston, Massachusetts	$409K	–	–	–
35	35 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$387K	+$1.81K	+100	+0.4%
36	36 Tudor Investment Corp Stamford, Connecticut	$327K	+$361K	+20,000	New
37	TA 37 Teachers Advisors New York	$324K	+$28.5K	+1,580	+9%
38	CS 38 Credit Suisse Zurich, Switzerland	$285K	+$316K	+17,480	New
39	39 D.E. Shaw & Co New York	$258K	+$286K	+15,819	New
40	40 Two Sigma Investments New York	$194K	+$214K	+11,879	New
41	41 New York State Common Retirement Fund Albany, New York	$191K	+$91.1K	+5,043	+76%
42	42 Renaissance Technologies New York	$181K	+$200K	+11,100	New
43	MLICM 43 Metropolitan Life Insurance Company (MetLife) New York	$159K	+$176K	+9,724	New
44	44 Norges Bank Oslo, Norway	$156K	+$181K	+10,000	New
45	45 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	$143K	-$4.51K	-250	-3%
46	46 Barclays London, United Kingdom	$132K	+$6.17K	+342	+4%
47	47 Wells Fargo San Francisco, California	$125K	–	–	–
48	NFA 48 Nationwide Fund Advisors Columbus, Ohio	$117K	–	–	–
49	AIG 49 American International Group New York	$106K	+$163	+9	+0.1%
50	50 Morgan Stanley New York	$70K	+$77.2K	+4,273	New

MYOK Hedge Fund Activity: Q3 2016 in Review

63 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q3 2016, worth a combined $233M — up 89% from $123M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new MYOK positions and 1 closed out — a net gain of 18 holders — while 31 added to existing stakes and 7 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $27M. The largest seller was JP Morgan Chase, cutting an estimated $3.22M.

63 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q3 2016, up from 45 in Q2 2016.
Funds reported $233M of MyoKardia, Inc. Common Stock stock for Q3 2016, up 89% quarter-over-quarter.
19 funds opened new MyoKardia, Inc. Common Stock positions in Q3 2016 and 1 closed out, a net change of +18 holders.
The largest MyoKardia, Inc. Common Stock buyer in Q3 2016 was Wellington Management Group, an estimated $27M added.
The largest MyoKardia, Inc. Common Stock seller in Q3 2016 was JP Morgan Chase, an estimated $3.22M sold.

Based on aggregated 13F filings for Q3 2016.

MyoKardia, Inc. Common Stock MYOK